financetom
Business
financetom
/
Business
/
CoStar raises annual revenue forecast on increasing traffic to its websites
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CoStar raises annual revenue forecast on increasing traffic to its websites
May 25, 2025 9:18 PM

April 29 (Reuters) - Real estate information provider CoStar Group ( CSGP ) raised its

annual revenue forecast on Tuesday, benefiting from rising consumer traffic on its websites that

provide subscription-based services.

Real estate agents and customers rely on providers like CoStar Group ( CSGP ), which offers a

database of commercial real estate, with information on properties, leasing, sales, tenants and

demand statistics, among other data.

The Arlington, Virginia-based company's namesake commercial real estate business, CoStar ( CSGP ),

posted annualized net new bookings that were up 68% from a year ago in the first quarter.

LoopNet reported a 200% increase in annualized net new bookings for the quarter ended March

31.

The company now expects annual revenue in the range of $3.12 billion to $3.16 billion,

compared to its prior projection of between $2.99 billion and $3.02 billion.

Earlier in April, CoStar ( CSGP ) revamped its board and planned to review its capital allocation to

boost profitability and shares, as part of an agreement with hedge funds D.E. Shaw and Third

Point.

In late March, CoStar ( CSGP ) raised its bid for Australia's second-largest real estate classifieds

company, Domain Holdings, with the revised deal valued at A$2.80 billion ($1.80

billion).

The Homes.com owner sees second-quarter revenue in the range of $770 million to $775

million, while analysts expect $786.9 million.

For the first quarter, the company reported revenue of $732.2 million, which was slightly

ahead of estimates of $730 million.

($1 = 1.5584 Australian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Summit Therapeutics Raises $235 Million from Insiders, Institutional Investors
Summit Therapeutics Raises $235 Million from Insiders, Institutional Investors
Sep 12, 2024
07:43 AM EDT, 09/12/2024 (MT Newswires) -- Summit Therapeutics ( SMMT ) said Thursday it accepted offers to purchase a total of about 10.35 million shares at $22.70 apiece, raising approximately $235 million. About $79 million was raised by insiders, including Co-Chief Executive Officers Robert Duggan and Maky Zanganeh, while the remaining $156 million came from multiple biopharma institutional investors,...
Royal Bank of Canada Makes Katherine Gibson Permanent Chief Financial Officer
Royal Bank of Canada Makes Katherine Gibson Permanent Chief Financial Officer
Sep 12, 2024
07:40 AM EDT, 09/12/2024 (MT Newswires) -- Royal Bank of Canada ( RY ) announced Thursday that Katherine Gibson has been appointed Chief Financial Officer, effective immediately. Ms. Gibson has served as Interim Chief Financial Officer since April 5, 2024. Prior to this, she was Senior Vice President, Enterprise Finance & Controller with global responsibility for head office Finance, including...
Aya Gold & Silver to Spin Out Two Projects to New Africa-Focused Company
Aya Gold & Silver to Spin Out Two Projects to New Africa-Focused Company
Sep 12, 2024
07:39 AM EDT, 09/12/2024 (MT Newswires) -- Aya Gold & Silver ( AYASF ) said Thursday that it entered nonbinding term sheets to spin out its Amizmiz gold project in Morocco and grant an option on its Tijirit project in Mauritania to Mx2 Mining, a new North Africa-focused gold company backed by Aya. Mx2 will be led by Richard Clark...
Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors
Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors
Sep 12, 2024
07:37 AM EDT, 09/12/2024 (MT Newswires) -- Merck ( MRK ) said Thursday that Health Canada has approved Keytruda as a treatment for adults and children with unresectable or metastatic microsatellite instability-high or mismatch repair deficient solid tumors. The approval is based on the results of phase 2 trials, including data from 504 patients across more than 30 cancer types,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved